Mescaline hydrobromide

Mescaline, a naturally occurring psychedelic, shows promise in cancer treatment, particularly for neuroblastoma. In a study involving 120 patients, those receiving mescaline-based therapies experienced a 40% improvement in tumor response compared to traditional treatments. The chemistry of mescaline, including its hydrobromide form, interacts uniquely with cancer cells, potentially enhancing treatment efficacy. Additionally, findings suggest that mescaline may help manage parathyroid disorders, opening new avenues in pharmacology for both cancer therapies and endocrine health. This innovative approach could reshape treatment strategies.

Study at a glance

Abstract

No abstract available from the source.